Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.52
Price to sales ratio
0.34

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4400
NEPH
Nephros, Inc. - Common Stock
3.59 USD0.00%-2.71%+7.81%-5.77%38.98 M USD
4447
MLSS
Milestone Scientific, Inc. Common Stock
0.39 USD-2.50%+14.71%+11.43%-40.00%34.35 M USD
4614
RVP
Retractable Technologies, Inc. Common Stock
0.69 USD0.00%-2.82%-2.82%-0.09%20.66 M USD
4712
ZJYL
JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares
1.96 USD+4.81%+5.95%-20.33%+221.31%15.34 M USD

Frequently asked questions about Harvard Bioscience, Inc. - Common Stock

What is the Harvard Bioscience, Inc. - Common Stock stock price today?

The current price of Harvard Bioscience, Inc. - Common Stock (HBIO) is 6. Over the past 24 hours, the stock has changed by -1.96%. Follow the HBIO chart for real-time price dynamics.

What is the stock ticker of Harvard Bioscience, Inc. - Common Stock?

Harvard Bioscience, Inc. - Common Stock trades under the ticker HBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Harvard Bioscience, Inc. - Common Stock stock going up?

HBIO has changed by -6.54% over the last week, -3.07% over the last month, and +1295.35% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Harvard Bioscience, Inc. - Common Stock net income for the last quarter?

Harvard Bioscience, Inc. - Common Stock reported net income of -3.42 M for the last quarter. The previous quarter showed -2.85 M, which means net income changed by -20.27%.

How many employees does Harvard Bioscience, Inc. - Common Stock have?

As of the latest available data, Harvard Bioscience, Inc. - Common Stock has 339 employees. Workforce size can provide additional context about the company's scale and operations.

What is Harvard Bioscience, Inc. - Common Stock EBITDA?

Harvard Bioscience, Inc. - Common Stock EBITDA is 535 K, and its EBITDA margin is 2.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Harvard Bioscience, Inc. - Common Stock stock?

You can buy Harvard Bioscience, Inc. - Common Stock (HBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Harvard Bioscience, Inc. - Common Stock stock?

Investing in Harvard Bioscience, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HBIO chart and related analysis on metatrader.com as part of your research.

Harvard Bioscience, Inc. - Common Stock

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.

News